News
News Medical on MSN20m
Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancerFirst-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback